tetano
Editor, Senior Moderator
J Med Virol
. 2025 Jun;97(6):e70446.
doi: 10.1002/jmv.70446. Proteomics and Phosphoproteomics Characteristics of the Rhesus Macaque Lung Infected With Original SARS-CoV-2, Delta, and Omicron Variants
XiaoYue Tang[SUP] 1 [/SUP], YaNan Zhou[SUP] 2 [/SUP], Yan Sun[SUP] 1 [/SUP], Tao Ding[SUP] 1 [/SUP], QiaoChu Wang[SUP] 1 [/SUP], Chunmei Shi[SUP] 1 [/SUP], Zhiyi Zhang[SUP] 1 [/SUP], YeHong Yang[SUP] 1 [/SUP], Yue Wu[SUP] 1 [/SUP], JiangFeng Liu[SUP] 1 [/SUP], ShuaiYao Lu[SUP] 2 [/SUP], JunTao Yang[SUP] 1 [/SUP]
Affiliations
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains mutate rapidly, making it crucial to study their molecular mechanisms for swift vaccine and drug development. Here, we utilized host lung proteomic and phosphoproteomic profiling to investigate the underlying pathology caused by the variants. Lung tissues infected with wild-type GD108, Delta, or Omicron BA.1 variants showed overexpression of proteins and phosphoproteins linked to the innate immune pathway, particularly in the Omicron group, with high activation of NOD-receptor and RIG-I like receptor signaling pathways. Protein-protein interaction (PPI) analysis revealed six key proteins, including antiviral innate immune response receptor RIG-I (DDX58), and five interferon-related proteins (IFIT2, ISG15, MX1, STAT1, and EIF2AK2), highlighting the importance of the innate immune response in combating all three variants. Kinase prediction analysis suggested that six kinases (DAPK1, DAPK2, DAPK3, PRACK, TTK, and MAP2K2), potentially inhibited by Fostamatinib, were activated across all three variants, and might be potential drug targets, pending further verification. Omicron infection, compared to other mutants, significantly disrupted proteins related to pulmonary structural support, like integrin and collagens, and inhibited efferocytosis, reducing the host's ability to eliminate the pathogen. These findings suggest that innate immune activation and structural disruption may contribute to Omicron-related pathology, potentially being useful for research into the molecular mechanisms underlying lung injury from SARS-CoV-2 variants.
Keywords: COVID‐19; Delta variant; Omicron variant; SARS‐CoV‐2; innate immune response; lung; phosphoproteomic; proteomic.
. 2025 Jun;97(6):e70446.
doi: 10.1002/jmv.70446. Proteomics and Phosphoproteomics Characteristics of the Rhesus Macaque Lung Infected With Original SARS-CoV-2, Delta, and Omicron Variants
XiaoYue Tang[SUP] 1 [/SUP], YaNan Zhou[SUP] 2 [/SUP], Yan Sun[SUP] 1 [/SUP], Tao Ding[SUP] 1 [/SUP], QiaoChu Wang[SUP] 1 [/SUP], Chunmei Shi[SUP] 1 [/SUP], Zhiyi Zhang[SUP] 1 [/SUP], YeHong Yang[SUP] 1 [/SUP], Yue Wu[SUP] 1 [/SUP], JiangFeng Liu[SUP] 1 [/SUP], ShuaiYao Lu[SUP] 2 [/SUP], JunTao Yang[SUP] 1 [/SUP]
Affiliations
- PMID: 40536091
- DOI: 10.1002/jmv.70446
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains mutate rapidly, making it crucial to study their molecular mechanisms for swift vaccine and drug development. Here, we utilized host lung proteomic and phosphoproteomic profiling to investigate the underlying pathology caused by the variants. Lung tissues infected with wild-type GD108, Delta, or Omicron BA.1 variants showed overexpression of proteins and phosphoproteins linked to the innate immune pathway, particularly in the Omicron group, with high activation of NOD-receptor and RIG-I like receptor signaling pathways. Protein-protein interaction (PPI) analysis revealed six key proteins, including antiviral innate immune response receptor RIG-I (DDX58), and five interferon-related proteins (IFIT2, ISG15, MX1, STAT1, and EIF2AK2), highlighting the importance of the innate immune response in combating all three variants. Kinase prediction analysis suggested that six kinases (DAPK1, DAPK2, DAPK3, PRACK, TTK, and MAP2K2), potentially inhibited by Fostamatinib, were activated across all three variants, and might be potential drug targets, pending further verification. Omicron infection, compared to other mutants, significantly disrupted proteins related to pulmonary structural support, like integrin and collagens, and inhibited efferocytosis, reducing the host's ability to eliminate the pathogen. These findings suggest that innate immune activation and structural disruption may contribute to Omicron-related pathology, potentially being useful for research into the molecular mechanisms underlying lung injury from SARS-CoV-2 variants.
Keywords: COVID‐19; Delta variant; Omicron variant; SARS‐CoV‐2; innate immune response; lung; phosphoproteomic; proteomic.